Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C K LIU

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Nutrition, Health & Aging|October 31, 2017
Effect of Structured Physical Activity and Nutritional Supplementation on Physical Function in Mobility-Limited Older Adults: Results from the VIVE2 Randomized TrialR A Fielding, T G Travison, D R Kirn, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2007
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Journal of Medicinal Chemistry|December 28, 2002
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonistNatesan Murugesan, Zhengxiang Gu, Steven Spergel, et al.
Journal of Medicinal Chemistry|November 13, 2008
Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577Yan Shi, Chi Li, Stephen P O'Connor, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2011
Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitorsYan Shi, Stephen P O'Connor, Doree Sitkoff, et al.
Ageing Research Reviews|May 28, 2018
Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysisC Custodero, R T Mankowski, S A Lee, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|September 30, 2024
[Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)]M Hu, C Yang, H H Liu, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Nutrition, Health & Aging|October 31, 2017
Effect of Structured Physical Activity and Nutritional Supplementation on Physical Function in Mobility-Limited Older Adults: Results from the VIVE2 Randomized TrialR A Fielding, T G Travison, D R Kirn, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2007
Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Journal of Medicinal Chemistry|December 28, 2002
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonistNatesan Murugesan, Zhengxiang Gu, Steven Spergel, et al.
Journal of Medicinal Chemistry|November 13, 2008
Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577Yan Shi, Chi Li, Stephen P O'Connor, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2011
Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitorsYan Shi, Stephen P O'Connor, Doree Sitkoff, et al.
Ageing Research Reviews|May 28, 2018
Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysisC Custodero, R T Mankowski, S A Lee, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|September 30, 2024
[Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)]M Hu, C Yang, H H Liu, et al.
Pageof 8